Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...

The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

BERLIN - The scientist who won the race to deliver the first widely used coronavirus vaccine says people can rest assured the shots are safe, and the technology behind it will soon be used to fight ...

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

The children's parents discussed their decision with ABC News. Three American siblings have received their first dose of the Pfizer-BioNTech COVID-19 vaccine as part of global clinical trials for ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

Pfizer Inc. and BioNTech SE have announced that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior ...